Blood test could spot hidden cancers in High-Risk patients
NCT ID NCT04261972
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is developing a blood test to find early-stage tumors in people with hereditary cancer syndromes (high genetic risk for cancer). Researchers will collect blood samples and medical data from about 1,400 participants across Canada. They will also interview patients and doctors to see if this test is useful and practical for routine cancer screening.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEREDITARY CANCER SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
BC Cancer Agency
Vancouver, British Columbia, V5Z 4E6, Canada
-
Eastern Health
St. John's, Newfoundland and Labrador, A1B 3V6, Canada
-
IWK Health Centre
Halifax, Nova Scotia, B3K 6R8, Canada
-
Jewish General Hospital
Montreal, Quebec, H3T 1E2, Canada
-
Sinai Health System
Toronto, Ontario, M5G 1X5, Canada
-
University Health Network
Toronto, Ontario, M5G 2M9, Canada
-
Women's College Hospital
Toronto, Ontario, M5S 1B2, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a chatbot help close the gap in genetic cancer testing?
- New study aims to unlock why lynch syndrome patients still get cancer despite surveillance
- Massive study aims to unlock secrets of rare Cancer-Predisposing gene
- Robots vs. surgeons: which is better for hysterectomy?
- Texts and nudges may help more people get cancer genetic testing
- Simple blood test could spot cancer earlier in High-Risk individuals